Detalles de la búsqueda
1.
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Cancer Immunol Immunother
; 72(11): 3707-3716, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638980
2.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
iScience
; 26(11): 107970, 2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37860695
3.
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors.
Tumori
; 108(1): 47-55, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002648
4.
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature.
Cancers (Basel)
; 13(21)2021 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771566
5.
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: a case report.
Transl Lung Cancer Res
; 9(3): 787-792, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676339
6.
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC.
Lung Cancer
; 131: 78-85, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31027702
7.
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab.
Immunotherapy
; 10(8): 681-694, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882691
8.
Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
Clin Lung Cancer
; 19(5): e591-e596, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29801705
Resultados
1 -
8
de 8
1
Próxima >
>>